Literature DB >> 12779102

Acute renal failure due to non-Hodgkin lymphoma infiltration of the kidneys detected by ultrasonography and confirmed by positron emission tomography.

S Simsek1, A L Oen, E F I Comans, J J M v d Hoeven, J Zijlstra.   

Abstract

Acute renal failure (ARF) as a consequence of non-Hodgkin lymphoma infiltration of the kidneys (LIK) is an uncommon complication of non-Hodgkin lymphoma. In literature, ARF due to LIK is reported in progressive disease. A case of non-oliguric acute renal failure secondary to relapse of large B cell non-Hodgkin lymphoma primarily localized in the mediastinum is reported. LIK of both kidneys was diagnosed by ultrasonography, computer tomography scan and 18-fluorodeoxyglucose positron emission tomography. No other causes for renal failure were found. The prognosis of renal involvement in relapsed non-Hodgkin lymphoma is poor, as is demonstrated by our case.

Entities:  

Mesh:

Year:  2003        PMID: 12779102

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  4 in total

1.  Acute kidney injury secondary to renal large B-cell lymphoma: role of early renal biopsy.

Authors:  Suhail Al-Salam; Ahmad Shaaban; Maha Alketbi; Naveed U Haq; Samra Abouchacra
Journal:  Int Urol Nephrol       Date:  2010-03-31       Impact factor: 2.370

2.  Diffuse large B-cell lymphoma presenting as bilateral renal infiltration leading to acute kidney injury.

Authors:  Tomoe Okubo; Shuma Hirashio; Minako Shimizu; Yoshiaki Kuroda; Shigehiro Doi; Takao Masaki
Journal:  CEN Case Rep       Date:  2017-06-07

3.  Acute kidney injury requiring dialysis: a very unusual presentation of non-Hodgkin's lymphoma.

Authors:  Sofia Jorge; José António Lopes; Sara Gonçalves; Graça Esteves; José Alves do Carmo
Journal:  NDT Plus       Date:  2010-04-26

Review 4.  Molecular Mechanisms and Biomarkers Associated with Chemotherapy-Induced AKI.

Authors:  Letizia De Chiara; Gianmarco Lugli; Gianluca Villa; Valentina Raglianti; Faeq Husain-Syed; Fiammetta Ravaglia; Paola Romagnani; Elena Lazzeri
Journal:  Int J Mol Sci       Date:  2022-02-27       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.